Overview
Cantab Biopharmaceuticals Ltd is using cutting-edge technologies to develop biosuperior protein therapeutics that address sub-optimal, in-market characteristics of currently licensed biologics. The company has a focus within the therapeutic areas of haematology and infectious disease.
Current Products
Our research and development efforts are currently focussed on a number of products which we have identified as having significant potential for "biosuperior" development. Details of these products will be updated as they progress through development.